Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yeong C Kim

Showing results (1-10 of 28) with videos related to

Pageof 3
Sort By:
Scientific Reports|July 29, 2016
Exome-based Variant Detection in Core PromotersYeong C Kim, Jian Cui, Jiangtao Luo, et al.
Plos One|November 20, 2013
The genome of polymorphonuclear neutrophils maintains normal coding sequencesFengxia Xiao, Yeong C Kim, Hongxiu Wen, et al.
Frontiers in Oncology|May 6, 2016
Differences of Variable Number Tandem Repeats in XRCC5 Promoter Are Associated with Increased or Decreased Risk of Breast Cancer in BRCA Gene Mutation CarriersJian Cui, Jiangtao Luo, Yeong C Kim, et al.
Oncotarget|February 6, 2016
Prevalence and spectrum of BRCA germline variants in mainland Chinese familial breast and ovarian cancer patientsYeong C Kim, Linli Zhao, Hanwen Zhang, et al.
Genome Research|February 23, 2008
Scanning the human genome at kilobase resolutionJun Chen, Yeong C Kim, Yong-Chul Jung, et al.
Cell Transplantation|February 8, 2011
Alternatively expressed genes identified in the CD4+ T cells of allograft rejection miceJia Xu, Dan Wang, Chao Zhang, et al.
The Journal of Biological Chemistry|June 23, 2016
Transforming Growth Factor β Mediates Drug Resistance by Regulating the Expression of Pyruvate Dehydrogenase Kinase 4 in Colorectal CancerYang Zhang, Yi Zhang, Liying Geng, et al.
The Breast Journal|January 25, 2017
Single-base LOH can be used as Specific Marker to Classify BRCAx Familial Breast Cancer into More Homogenous SubtypesBradley Downs, Fengxia Xiao, Yeong C Kim, et al.
The Journal of Biological Chemistry|March 30, 2020
Withdrawal: Transforming growth factor β mediates drug resistance by regulating the expression of pyruvate dehydrogenase kinase 4 in colorectal cancerYang Zhang, Yi Zhang, Liying Geng, et al.
European Journal of Cancer (Oxford, England : 1990)|December 15, 2018
Common genetic variants contribute to incomplete penetrance: evidence from cancer-free BRCA1 mutation carriersBradley Downs, Simon Sherman, Jian Cui, et al.
Pageof 3

Showing results (1-10 of 28) with videos related to

Sort By:
Pageof 3
Scientific Reports|July 29, 2016
Exome-based Variant Detection in Core PromotersYeong C Kim, Jian Cui, Jiangtao Luo, et al.
Plos One|November 20, 2013
The genome of polymorphonuclear neutrophils maintains normal coding sequencesFengxia Xiao, Yeong C Kim, Hongxiu Wen, et al.
Frontiers in Oncology|May 6, 2016
Differences of Variable Number Tandem Repeats in XRCC5 Promoter Are Associated with Increased or Decreased Risk of Breast Cancer in BRCA Gene Mutation CarriersJian Cui, Jiangtao Luo, Yeong C Kim, et al.
Oncotarget|February 6, 2016
Prevalence and spectrum of BRCA germline variants in mainland Chinese familial breast and ovarian cancer patientsYeong C Kim, Linli Zhao, Hanwen Zhang, et al.
Genome Research|February 23, 2008
Scanning the human genome at kilobase resolutionJun Chen, Yeong C Kim, Yong-Chul Jung, et al.
Cell Transplantation|February 8, 2011
Alternatively expressed genes identified in the CD4+ T cells of allograft rejection miceJia Xu, Dan Wang, Chao Zhang, et al.
The Journal of Biological Chemistry|June 23, 2016
Transforming Growth Factor β Mediates Drug Resistance by Regulating the Expression of Pyruvate Dehydrogenase Kinase 4 in Colorectal CancerYang Zhang, Yi Zhang, Liying Geng, et al.
The Breast Journal|January 25, 2017
Single-base LOH can be used as Specific Marker to Classify BRCAx Familial Breast Cancer into More Homogenous SubtypesBradley Downs, Fengxia Xiao, Yeong C Kim, et al.
The Journal of Biological Chemistry|March 30, 2020
Withdrawal: Transforming growth factor β mediates drug resistance by regulating the expression of pyruvate dehydrogenase kinase 4 in colorectal cancerYang Zhang, Yi Zhang, Liying Geng, et al.
European Journal of Cancer (Oxford, England : 1990)|December 15, 2018
Common genetic variants contribute to incomplete penetrance: evidence from cancer-free BRCA1 mutation carriersBradley Downs, Simon Sherman, Jian Cui, et al.
Pageof 3